ストックスクリーナーアプリを入手
16.04
1.71%
0.27
アフターアワーズ：
15.97
-0.07
-0.44%
前日終値:
$15.77
開ける：
$15.86
24時間の取引高:
928.33K
Relative Volume:
0.89
時価総額：
$2.08B
収益：
$283.06M
当期純損益:
$287.20M
株価収益率:
7.7223
EPS:
2.0771
ネットキャッシュフロー:
$135.69M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+2.75%
6か月 パフォーマンス:
+11.00%
1年 パフォーマンス:
+94.19%
1日の値動き範囲:
$15.67
$16.11
1週間の範囲:
$14.83
$16.11
52週間の値動き範囲:
$7.285
$16.88
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
Compare AUPH vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
16.04 | 2.05B | 283.06M | 287.20M | 135.69M | 2.0771 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-03 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-11-07 | アップグレード | Jefferies | Hold → Buy |
| 2025-11-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-07-30 | 再開されました | H.C. Wainwright | Buy |
| 2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-05 | 開始されました | Cowen | Outperform |
| 2020-01-10 | 開始されました | Jefferies | Buy |
| 2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
| 2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
MSN Money - MSN
Pharma Co. Investor Sues Over Misleading Aurinia Deal - Law360
Short Interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Decreases By 15.7% - MarketBeat
AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) Screens Strong on Minervini Trend Template and High Growth Momentum - ChartMill
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
Kezar Life Sciences (NASDAQ: KZR) details Aurinia tender offer, pay and ownership - Stock Titan
Aurinia earnings on deck: Can new leadership sustain growth? By Investing.com - Investing.com India
Aurinia earnings on deck: Can new leadership sustain growth? - Investing.com
Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN
Aruinia discloses FDA information request on Lupkynis amid top regulator’s exit - MSN
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - MSN
Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN
AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill
FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - MSN
How (AUPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 By Investing.com - Investing.com India
Aurinia Pharmaceuticals stock hits 52-week high at $16.72 - Investing.com Australia
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Aurinia (NASDAQ: AUPH) details 2026 virtual AGM, auditor and say-on-pay - Stock Titan
Aurinia (AUPH) Stock: Risk Exposure (Grinds Higher) 2026-04-18Viral Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Aurinia (AUPH) Stock Breakout Watch (-1.37%) 2026-04-16Risk Analysis - UBND thành phố Hải Phòng
Tudor Investment Corp ET AL Buys Shares of 65,964 Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 12-Month HighHere's What Happened - MarketBeat
Trading Systems Reacting to (AUPH) Volatility - Stock Traders Daily
Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan
Ideas Watch: Is Aurinia Pharmaceuticals Inc gaining market sharePortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn
Guidance Update: Does Aurinia Pharmaceuticals Inc stock have upside surprise potentialBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan
Dow Update: Whats the profit margin of Aurinia Pharmaceuticals Inc2026 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Proxy StatementNotice of Shareholders Meeting (preliminary) (pre 14a) - ADVFN
Ritholtz Wealth Management Acquires 174,301 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
AUPHAurinia Announces Results of Annual General Meeting - ADVFN
RSI Check: Can Aurinia Pharmaceuticals Inc grow without external fundingDip Buying & Short-Term High Return Ideas - baoquankhu1.vn
Downgrade Watch: Why is Aurinia Pharmaceuticals Inc stock going up2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Will Aurinia Pharmaceuticals Inc benefit from government policyEarnings Risk Report & Risk Managed Trade Strategies - baoquankhu1.vn
7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments - GlobeNewswire Inc.
Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm
AUPH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):